Dr. Isabel Galante Romo

Teaching activity

  • Practical Teaching Collaborator of the Department of Surgery of the Faculty of Medicine of the Complutense University at the San Carlos University Hospital during the academic years 2006-07, 2007-08 and 2008-09.2009-10, 2010-11, 2011-12, 2012 -13, 2013-14; 2014-15; 2015-16; 2016-17. (From 2008 to present)
  • Postgraduate teaching for the training of Urology Residents from 2008 to the present.
  • Postgraduate teaching for the training of residents of other rotating specialties in Urology from 2008 to the present.
  • Resident Tutor of the San Carlos Clinical Hospital since 2013.

Participation and collaboration in courses and conferences

  • As a Speaker, Moderator or Scientific Committee I have participated in more than 40 courses and conferences. Highlight those carried out in collaboration with the Spanish Association of Urology and the Spanish Society of Laparoscopic and Robotic Surgery, of which I have been a member since 2003, having participated annually in the different events and meetings.

Communications and posters

  • First Signatory in 50 posters/communications at National Congresses.
  • First signatory in 3 posters/communications at International Congresses.
  • Collaborating author on more than 200 posters/communications at both national and international conferences.

Clinical trials and research projects

  • Attached to the OGS Ingestion Group.21 Research in Urology. Oncology and New Technologies; belonging to the Biomedical Research Institute. HCSC since 2011.
  • Pilot study to analyze the Tissue Proteomic Map and the immunohistochemical profile of transitional cell carcinoma located in the bladder. San Carlos Clinical Hospital in Madrid and the Urology Service of the Puerta de Hierro Hospital in Madrid.
  • Multicenter study, with two dose levels of a purified neurotoxin complex BOTOX® (Botulinum toxin type A) followed by treatment with BOTOX® in patients with urinary incontinence due to neurogenic detrusor overactivity Study Number: 191622-516. Promoter: Allergan Limited.
  • CO-SDT STUDY: “Comorbidities in patients with Testosterone Deficiency Syndrome.” It started in October 2009 and ends in October 2010. February 2011.
  • Phase III Multicente randomized study to investigate the efficacy and safety of atezolizumab compared with chemotherapy in patients with locally advanced or metastatic urothelial bladder cancer after failure with platinum-containing chemotherapy. GO-29294. December 2016.
  • Roche Study MO 29983. Feb 2017.
  • Roche Study WO 3070. July 2016.
  • Study GU 118. Prahealthsciences. February 2017.
  • Pfizer B9991001 study. Multi-enterprise multinational randomized phase III with parallel groups on avelumab. Nov 2016.
  • Certificate of off-site training as a console surgeon. April 2008. (20 teaching hours)
  • EBU Written examination following the 2nd ESU Masterclass on Medical Oncology for Urologists. Barcelona, July 1, 2007.
  • 2007 European Board Examination in Urology. Written Examination. Prague, 12 September 2007.
  • Expert Title with Distinction in UNED Course 2013-14- Statistics Applied to Health Sciences. 500 H. 20 credits.
  • Master Uro-Oncology. Uned 2018-2019. Outstanding.
  • Graduate in Medicine from the Complutense University of Madrid (1996-2002 academic year) with an average grade of Notable.
  • MIR call passed in 2003 in the first call.
  • The Doctoral Courses have been passed with an Outstanding rating by the Complutense University of Madrid, Department of General Surgery, branch of Urology.
  • Presentation and Approval of a Research Project for Research Sufficiency before the Court of the Department of Surgery of the Complutense University of Madrid in 2005 with the title “Current surgical treatment of Female Stress Urinary Incontinence”.
  • Training as a Resident Doctor in the Urology Specialty. San Carlos Clinical Hospital. 2003-2008. Urology Specialist.
  • Consolidation of Plaza in the Madrid Health System as a Specialist in Urology in 2012. In Service Commission at the San Carlos Clinical Hospital from February 2012 to date.
  • 21 articles Indexed in PubMed.
  • Collaboration in several chapters of the Atlas of Urinary Incontinence and Pelvic Floor. Editor J. Moreno Sierra. Madrid, 2007. ISBN-13: 978-84-690-3999-1.
  • J. Moreno Sierra, I. Galante Romo, J. Blázquez Izquierdo, S. Prieto Nogal, A. Silmi Moyano. Current treatment of erectile dysfunction. JANUARY 18-24 November 2005. Key R. Pages 49-52.
  • JJ Moreno Sierra, L. Fernández Montarroso, I. Galante Romo, MP Mazuecos López, E. Blanco Jiménez, A. Silmi Moyano. Surgical treatment of localized prostate cancer. Medical Oncology Monographs 2005. Revision Key. YOU & US Publishing, SA. Madrid. Pages 5-21
  • Galante Romo, MI; Prieto Nogal, SB; Gómiz, JJ. Non-aggressive high-grade transitional carcinoma. Section 2: Urological Oncology of the Book: 6th Clinical Case Competition for Urologists in training. Spanish Association of Urology.